| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 29,452 | $14.77 | $435,085.04 | -21.4% | |
| May 21, 2015 | PBH Prestige Consumer Healthcare Inc. | Boyko Jean A | SVP, Science And Technology | Sell | 12,583 | $43.12 | $542,578.96 | -44.7% | |
| May 21, 2015 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 16,000 | $35.62 | $569,898.40 | -100% | |
| May 20, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 190,000 | $73.43 | $13,951,320.00 | -0.1% | |
| May 20, 2015 | TXMD Therapeuticsmd, Inc. | Krassan Mitchell | EVP, Chief Strategy Officer | Sell | 60,000 | $6.56 | $393,354.00 | -100% | |
| May 20, 2015 | PBH Prestige Consumer Healthcare Inc. | Mannelly Matthew | President And CEO | Sell | 112,731 | $43.30 | $4,881,073.05 | -51.4% | |
| May 19, 2015 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 2,801 | $8.00 | $22,408.00 | +0.2% | |
| May 19, 2015 | TLPH Talphera, Inc. | Rosen Howard B | Intermin CEO | Buy | 35,400 | $0.00 | - | +805.6% | |
| May 19, 2015 | PBH Prestige Consumer Healthcare Inc. | Connors Timothy | EVP, Sales &Marketing | Sell | 73,648 | $43.11 | $3,174,965.28 | -44.6% | |
| May 19, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 3,000 | $14.94 | $44,824.50 | -7.7% | |
| May 19, 2015 | PBH Prestige Consumer Healthcare Inc. | Cowley Samuel C54 | General Counsel And VP | Sell | 12,495 | $43.42 | $542,532.90 | -27.8% | |
| May 19, 2015 | HROW Harrow, Inc. | Miloni Donald Paul | 10% Owner | Sell | 410,000 | $8.00 | $3,280,198.00 | -28.1% | |
| May 19, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 18,000 | $36.73 | $661,140.00 | -14.3% | |
| May 19, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 18,000 | $36.73 | $661,140.00 | -14.3% | |
| May 18, 2015 | PAHC Phibro Animal Health Corp | Dagger Thomas G | SVP, Gen Counsel And Corp Sec | Sell | 4,000 | $36.48 | $145,936.80 | -100% | |
| May 15, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $72.83 | $14,566,400.00 | -0.2% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Tpg Group Holdings (sbs) Advisors, Inc.86 | Former 10% Owner | Buy | 100,000 | $12.00 | $1,200,000.00 | +8.2% | |
| May 12, 2015 | TXMD Therapeuticsmd, Inc. | Russell Angus C. | Director | Buy | 35,000 | $6.15 | $215,316.50 | New | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Hirsch David | Director, 10% Owner | Buy | 200,000 | $12.00 | $2,400,000.00 | +6.4% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Skyline Venture Partners V LP | 10% Owner | Buy | 150,000 | $12.00 | $1,800,000.00 | +5.4% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Freund John Gordon79 | Director, 10% Owner | Buy | 150,000 | $12.00 | $1,800,000.00 | +5.4% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Heron Patrick J87 | Director, 10% Owner | Buy | 150,000 | $12.00 | $1,800,000.00 | +8.6% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Frazier Healthcare Vi, L.P. | 10% Owner | Buy | 150,000 | $12.00 | $1,800,000.00 | +8.6% | |
| May 12, 2015 | EBS Emergent Biosolutions Inc. | Harsanyi Zsolt | Director | Sell | 20,800 | $30.06 | $625,296.00 | -26.6% | |
| May 12, 2015 | EBS Emergent Biosolutions Inc. | Bailey Sue | Director | Sell | 19,920 | $30.12 | $600,002.40 | -20.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.